Iowa awards $2 million CARES Act grant to universities to study COVID-19 nanovaccine
A $2 million grant of federal CARES Act funding distributed by the state of Iowa will support university research of a nanovaccine to protect against COVID-19 infections.
The project will build on previous research and existing patents by Iowa State University and University of Iowa researchers affiliated with the Nanovaccine Institute based at Iowa State. The fast-track project is expected to be largely completed by the end of the year.
